According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...

When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...

When the doctors do tests to diagnose cancer, they always check your lymph nodes to see how much it has spread. This information not only helps them figure out how advanced the cancer is but also ...

Former President Joe Biden's office announced Sunday that he has been diagnosed with an "aggressive" form of prostate cancer, which has spread to his bones. But it said the cancer appears to be ...

Survivorship in metastatic prostate cancer is seen as chronic management, focusing on quality of life through physical and emotional management. Carotuximab combined with Erleada shows a favorable ...

Zoledronic acid reduced fracture risk by 27% in men with metastatic prostate cancer receiving ADT in the STAMPEDE trial. Patients with non-metastatic disease showed no significant fracture benefit ...

Sept. 18, 2025 -- About 1 in 8 men will face a prostate cancer diagnosis. Early-stage prostate cancer often has no symptoms—so how should men approach screening and advocacy? What disparities do Black ...

Metastatic prostate cancer is cancer that began in the prostate but has spread to other parts of the body. There's no cure, but there are a number of effective treatments you can discuss with a ...

Exploring potential biomarkers for FOLFIRI plus aflibercept as second-line treatment in patients with metastatic colorectal cancer. The distribution of stained and metastatic lymph nodes (n=146).